PUBLIC CONTRACT · 2023
Medicamentos usados nas afeções oculares e otorrinolaringológicas ao abrigo CPA 2021/49 dos SPMS
- Contract value
- €1,792.80
- Signed on
- 22 November 2023
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10776034PUBLISHED DESCRIPTION
PV/1264/2023
Parties involved
- Place of performance
- Portugal, Porto, Porto
- NUTS region
- PT11A - Área Metropolitana do Porto
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- AbbVie, LDA · Tax ID 510229050
- Bidder
- NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA · Tax ID 500063524
- Bidder
- BAUSCH & LOMB, S.A.- SUCURSAL EM PORTUGAL · Tax ID 980218764
- Bidder
- DAVI · Tax ID 508309450
- Bidder
- GlaxoSmithKline - Produtos Farmacêuticos, Lda. · Tax ID 500139962
- Bidder
- TECNIFAR-INDUSTRIA TECNICA FARMACEUTICA SA · Tax ID 500280436
Values and timeline
- Contract price
- €1,792.80
- Procedure base price
- €300,595.91
- Total effective price
- Not reported on Portal BASE
- Publication date
- 19 June 2024
- Award date
- 18 October 2023
- Signing date
- 22 November 2023
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/49 - Medicamentos usados nas afeções oculares e otorrinolaringológicas
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6749151
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.